Antonia Lopez-Girona

USPTO Granted Patents = 39 (Patent Applications = 19)

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 13 (Patent Applications = 23)

Average Co-Inventor Count = 5.6

ph-index = 7

Forward Citations = 133(Granted Patents)

Company Filing History:

Signal Pharmaceuticals, Inc.

patents

2 out of 1,186

The Scripps Research Institute

patents

4. 2 out of 2,076

Janssen Pharmaceutica Nv

6. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12474342 - Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies (2025-11-18),

2. 12396995 - Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use (2025-08-26),

3. 12178822 - Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dion (2024-12-31),

4. 12103923 - Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione (2024-10-01),

5. 12029738 - Antiproliferative compounds and methods of use thereof (2024-07-09),

6. 11945804 - Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith (2024-04-02),

7. 11733233 - Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases (2023-08-22),

8. 11726080 - Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile (2023-08-15),

9. 11666579 - Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione (2023-06-06),

10. 11628172 - Methods of treating chronic lymphocytic leukemia using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione (2023-04-18),

11. 11590117 - Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide (2023-02-28),

12. 11583536 - Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use (2023-02-21),

13. 11460471 - Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies (2022-10-04),

14. 11419861 - Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases (2022-08-23),

15. 11390617 - Methods of treating non-Hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione (2022-07-19),

Title: Antonia Lopez-Girona: Pioneering Inventor from San Diego

Introduction: Antonia Lopez-Girona is a trailblazing inventor hailing from the vibrant city of San Diego, California. Her innovative spirit and dedication to creating impactful solutions have made her a prominent figure in the world of patents and inventions.

Latest Patents: Antonia Lopez-Girona holds several groundbreaking patents in the fields of renewable energy technologies and sustainable materials. Her most recent patent involves a revolutionary method for harnessing solar energy in urban environments, showcasing her commitment to environmental sustainability.

Career Highlights: With a background in engineering and a passion for sustainability, Antonia has led numerous successful projects that have garnered international recognition. Her career highlights include receiving prestigious awards for her contributions to clean technology and being invited to speak at renowned innovation conferences worldwide.

Collaborations: Throughout her career, Antonia Lopez-Girona has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life. Her ability to work across disciplines and industries has led to the development of cutting-edge technologies with real-world applications.

Conclusion: Antonia Lopez-Girona's innovative spirit and commitment to sustainability continue to drive her forward as a prominent inventor in San Diego and beyond. Her contributions to the field of renewable energy and clean technologies have not only earned her accolades but have also made a lasting impact on the world we live in.

This text is generated by artificial intelligence and may not be accurate.